Randomised phase II trial of gemcitabine and nab-paclitaxel with necuparanib or placebo in untreated metastatic pancreas ductal adenocarcinoma
Eileen M. O’Reilly, Diletta Barone, Devalingam Mahalingam, Tanios Bekaii‐Saab, Spencer H. Shao, Julie Wolf, Molly Rosano, Silva Krause, Donald Richards, Kenneth H. Yu, James Roach, Keith T. Flaherty, David P. Ryan
Topics & Concepts
MedicineGemcitabinePlaceboHazard ratioClinical endpointInternal medicineInterim analysisPancreatic cancerSurgeryOncologyConfidence intervalChemotherapyCancerRandomized controlled trialPathologyAlternative medicinePancreatic and Hepatic Oncology ResearchPeptidase Inhibition and AnalysisNeuroendocrine Tumor Research Advances